Discovery of New thieno[2,3- d ]pyrimidines as EGFR Tyrosine Kinase Inhibitors for Cancer Treatment
Future Medicinal Chemistry · 2023
DOI: 10.4155/fmc-2023-0086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2023. Verfasst von Eman A Sobh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Chemistry Department, Faculty of Pharmacy, Menoufia University, Menoufia, Egypt. Hauptthemen laut MEDLINE: Antineoplastic Agents, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Princess Nourah Bint Abdulrahman University, AlMaarefa University.
Abstract (Originalsprache)
Background
EGFR has been considered a vital molecular target in cancer management.
Aim
The discovery of new thieno[2,3-d]pyrimidine derivatives as EGFR tyrosine kinase inhibitors.
Methods
Nine derivatives were designed, synthesized and subjected to in vitro and in silico studies.
Results
Compound 7a significantly inhibited the growth of HepG2 and PC3 cells for both EGFR wild-type and EGFRT790M. Compound 7a caused a significant apoptotic effect, arresting HepG2 cells' growth in the S and G2/M phases. Docking and molecular dynamics simulation studies confirmed the correct and stable binding modes of the synthesized compounds against the active sites.
Conclusion
Compound 7a is a promising dual EGFR inhibitor for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Menoufia University, Menoufia, Egypt.
- Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt.
- Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, 13713, Saudi Arabia.
- Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, PO Box 84428, Riyadh, 11671, Saudi Arabia.
- Biophysics Department, Faculty of Science, Cairo University, Cairo, 12613, Egypt.
- Pharmacognosy & Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt.
ORCID-Profile: Eman A Sobh, Mohammed A Dahab, Eslam B Elkaeed, Aisha A Alsfouk, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
Förderung
- Princess Nourah Bint Abdulrahman University
- AlMaarefa University
Zitieren
APA
Sobh, E. A., Dahab, M. A., Elkaeed, E. B., Alsfouk, A. A., Ibrahim, I. M., Metwaly, A. M., & Eissa, I. H. (2023). Discovery of New thieno[2,3- d ]pyrimidines as EGFR Tyrosine Kinase Inhibitors for Cancer Treatment. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0086
Vancouver
Sobh EA, Dahab MA, Elkaeed EB, Alsfouk AA, Ibrahim IM, Metwaly AM, et al. Discovery of New thieno[2,3- d ]pyrimidines as EGFR Tyrosine Kinase Inhibitors for Cancer Treatment. Future Medicinal Chemistry. 2023. doi:10.4155/fmc-2023-0086
BibTeX
@article{Sobh2023,
author = {Sobh, Eman A and Dahab, Mohammed A and Elkaeed, Eslam B and Alsfouk, Aisha A and Ibrahim, Ibrahim M and Metwaly, Ahmed M and Eissa, Ibrahim H},
title = {Discovery of New thieno[2,3- d ]pyrimidines as EGFR Tyrosine Kinase Inhibitors for Cancer Treatment},
journal = {Future Medicinal Chemistry},
year = {2023},
doi = {10.4155/fmc-2023-0086}
}
EUVIMED